Hormonal
Patients with severe obesity and Type 2 Diabetes experience a greater reduction in all-cause mortality from bariatric surgery compared to those with severe obesity alone.
If you have severe obesity and Type 2 Diabetes, bariatric surgery offers an even greater survival benefit than for those with obesity alone. This makes it a particularly strong consideration for managing your health and longevity.
The subgroup analysis for T2D status showed that patients with T2D who had undergone bariatric surgery had a pooled HR of all-cause mortality of 0.49 (95% CI: 0.45–0.54, P < 0.001, I2 = 0%) compared with matched nonsurgical subjects, and patients without T2D who had undergone bariatric surgery had a pooled HR of all-cause mortality of 0.68 (95% CI: 0.57–0.82, P < 0.001, I2 = 0%) compared with matched nonsurgical subjects. The difference between the T2D subgroup and no T2D subgroup was statistically significant (heterogeneity between subgroups: P = 0.001, I2 = 90.5%, Fig. 4).
Why this rating
Based on subgroup analysis of a large meta-analysis; heterogeneity was high between subgroups, suggesting variability.
Source
Disease-specific mortality and major adverse cardiovascular events after bariatric surgery: a meta-analysis of age, sex, and BMI-matched cohort studies
Beibei Cui et al. · International Journal of Surgery · 2023
DOI 10.1097/js9.0000000000000066
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →